All stock lists
CRISPR Therapeutics AG (NASDAQ:CRSP)
CH · Delayed Price · Currency is USD
Healthcare · Biotechnology
48.95-0.45 (-0.90%)
Insider Score
––Not scored
CRSP Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CRSP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 10.18 M | 1.46 M | 864.00 K | 889.00 K | 892.00 K | 865.00 K |
| Revenue Growth (YoY) | 1041.37 % | 68.55 % | -97.53 % | 47.67 % | 72.53 % | 71.63 % |
| Cost of Revenue | 44.57 M | 50.25 M | 59.36 M | 64.69 M | 49.75 M | 57.51 M |
| Gross Profit | -34.39 M | -48.79 M | -58.50 M | -63.80 M | -48.86 M | -56.64 M |
| SG&A Expense | 15.45 M | 17.18 M | 18.40 M | 16.93 M | 18.92 M | 19.30 M |
| R&D Expense | 64.95 M | 68.57 M | 77.86 M | 58.90 M | 65.29 M | 72.48 M |
| Operating Expenses | 80.41 M | 81.46 M | 96.26 M | 68.25 M | 84.21 M | 91.78 M |
| Operating Income | -114.80 M | -130.25 M | -154.76 M | -132.06 M | -133.07 M | -148.42 M |
| Pretax Income | -90.19 M | -122.09 M | -130.00 M | -105.82 M | -207.26 M | -134.89 M |
| Tax Provision | 960.00 K | 839.00 K | 614.00 K | 619.00 K | 1.29 M | 1.11 M |
| Net Income | -91.15 M | -122.93 M | -130.61 M | -106.44 M | -208.55 M | -136.00 M |
| EPS (Basic) | -0.94 | -1.28 | -1.37 | -1.17 | -2.40 | -1.58 |
| EPS (Diluted) | -0.94 | -1.28 | -1.37 | -1.17 | -2.40 | -1.58 |
| Shares Outstanding | 96.51 M | 96.05 M | 89.93 M | 91.31 M | 87.07 M | 85.94 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.